Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

There are no buyers in sight and we have lousy Q2 2015 numbers to look forward to, the total divestiture if 4694 to look forward to (at a HUGE financial loss to the company), the first of many Manocept letdowns should be released soon, and even more unimaginable bad news that Brent Larson and Thom Tulip shared with their effing short friends 2-3 years ago. The patience of every investor of this stock is truly amazing. The next shareholder meeting will be interesting.

If a buyout from a major pharmaceutical was offered at 3.40 per share, does anyone else agree that Brent Larson would insist on selling the company for 0.75/share?

After all, he owes it to his short friends to ram it to the retail shareholder eternally. Of that, he had done a marvelous job! More free shares for Brent NOW!